Suppr超能文献

普萘洛尔和酚妥拉明对蛛网膜下腔出血后心肌坏死的影响。

Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage.

作者信息

Neil-Dwyer G, Walter P, Cruickshank J M, Doshi B, O'Gorman P

出版信息

Br Med J. 1978 Oct 7;2(6143):990-2. doi: 10.1136/bmj.2.6143.990.

Abstract

A study was set up to assess the effect on the clinical course of subarachnoid haemorrhage (SAH) of giving propranolol 80 mg eight-hourly plus phentolamine 20 mg three-hourly by mouth for three weeks. Out of the 90 patients studied, 14 died. Two of the deaths occurred in an open pilot study of 10 patients, the remaining 12 deaths occurring in patients in a randomised double-blind placebo-controlled study. Postmortem examination was carried out on 12 of the patients, six of whom had been receiving placebo and six propranolol plus phentolamine. Necrotic myocardial lesions were present in the hearts of all six patients (age range 30-59 years) who died while taking placebo (all had had abnormal electrocardiograms (ECGs). In contrast, no necrotic lesions were found in the hearts of the six patients (age range 28-59) who died while receiving the drugs (all had previously had normal ECGs). We conclude that the necrotic myocardial lesions were induced by catecholamines and that propranolol had a cardioprotective effect. While death from a further haemorrhage in cases of SAH is not affected by propranolol and phentolamine, propranolol may have a beneficial effect in other potentially lethal stresses.

摘要

开展了一项研究,以评估每8小时口服80毫克普萘洛尔加每3小时口服20毫克酚妥拉明,持续三周,对蛛网膜下腔出血(SAH)临床病程的影响。在研究的90名患者中,14人死亡。其中2例死亡发生在10名患者的开放性预试验中,其余12例死亡发生在随机双盲安慰剂对照研究的患者中。对12名患者进行了尸检,其中6人接受安慰剂,6人接受普萘洛尔加酚妥拉明。所有6名服用安慰剂时死亡的患者(年龄在30至59岁之间)心脏均出现坏死性心肌病变(所有人心电图(ECG)均异常)。相比之下,接受药物治疗时死亡的6名患者(年龄在28至59岁之间)心脏未发现坏死性病变(所有人之前心电图均正常)。我们得出结论,坏死性心肌病变是由儿茶酚胺引起的,普萘洛尔具有心脏保护作用。虽然SAH患者再次出血导致的死亡不受普萘洛尔和酚妥拉明影响,但普萘洛尔在其他潜在致命应激中可能具有有益作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f857/1607890/c24f32046aa1/brmedj00147-0019-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验